Company Performance Metrics
Oncomedics is a biotechnology company that specializes in the research of personalized treatments against cancer, and the development of a system of diagnosis customized to individual treatment. The company also operates as a contract research organization that offers specialized services in the evaluation of novel anti-tumor agents during
pre-clinical and clinical screening. In addition, it conducts internal research and development programs focusing on the development of the oncogramme, a new predictive assay in order to perform individualized therapy against cancer; and works on various ex vivo tumor cell types in order to help clinical and pharmaceutical anti-cancer researches, such as breast, colon, ovarian, and prostatic cancers. The company was founded in 2006 and is based in Limoges, France.
